R factors conferring high-level resistance to trimethoprim and sulphonamides were identified in bacteria causing infections in patients at three London hospitals in 1971 (Fleming, Datta & Griineberg, 1972) . All were members of the W compatability group and came from the Camden area .
In April 1972 strains of Escherichia coli highly resistant to trimethoprim were isolated from calves at Frant, Kent, which is about 30 miles from the Camden area of London. The calves had been treated with large doses of a trimethoprim-sulphonamide preparation (Fleming, in preparation) . The trime t hoprim-resistant strains had various patterns of multiple drug resistance (always including resistance to sulphonamides) and from them various R factors were transferred to E. coli KI2. Trimethoprim resistance was transferred with resistance to streptomycin, separately from resistance to sulphonamides or other drugs. Methods were as described previously (Fleming et al. 1972 ).
An example of the trimethoprim-streptomycin resistance factors (R483) was studied in strains of Escherichia coli K12. Methods were as described by and by Coetzee, Datta & Hedges (1972) .
Phenotype of trimethoprim-streptomycin R factors
R483 and all other trimethoprim-streptomycin resistance factors tested were Ji-. R483 was therefore tested for compatability with all known classes of$-R factors.
In all transfers where the recipient was streptomycin-sensitive, exconjugants that had acquired trimethoprim resistance also acquired streptomycin resistance. Thus the two determinants are presumably markers of a single plasmid.
Like W plasmids, which confer resistance to trimethoprim (Fleming et al. 1972; Datta & Hedges I972), R483 determined resistance to > 1000 ,ug/ml of the drug. As well as streptomycin resistance, R483 conferred resistance to spectinomycin (Hedges, I 972 b).
Compatibility of R483
The frequency of transfer of R483 from Escherichia coli K12 sc16 to J53 with and without R factors of the various compatibility groups is given in Table I . R483 was compatible with all these, and therefore belonged to a new group, which we designate B.
Although R3oo and R483 are compatible (i.e. co-exist stably in K I~) , the presence of either in a recipient reduces the frequency of transfer of the other ( Table I) . From each 'double' the two plasmids were transmitted separately. Short communication 575 W plasmids which confer trimethoprim resistance also confer resistance to sulphonamides . These two synthetic drugs both affect folic acid metabolism. Trimethoprim is always used in conjunction with sulphonamide in human and veterinary medicine and thus any bacterium which acquires trimethoprim resistance is at no selective advantage unless it is also sulphonaniide-resistant. However, sulphonamide resistance is fairly common in Eschericlzia coli, and all the calf E. coli strains carrying trimethoprimstreptomycin resistance factors also carried other R factors conferring sulphonamide resistance.
Since R483 was compatible with R factors of all the compatibility classes so far described we designate it the prototype of a new class, B. The exclusion of R483 by R3oo and vice versa, although the two are compatible, contrasts with previous reports, where exclusion of one plasmid by another has usually been associated with incompatibility (Watanabe, I 969) . W plasmids, on the other hand, exert little if any exclusion; the resident plasmid is eliminated by entry of an incompatible replicon .
Trimethoprim is a newly introduced, synthetic antibacterial drug used in human medicine for 3 to 4 years (Garrod, 1969) and in veterinary medicine for a shorter time. Although bacteria have been exposed to the drug for so short a time, two independent R factor classes have emerged, conferring trimet hoprim resistance.
